Literature DB >> 28743507

Ketamine for Pain Management-Side Effects & Potential Adverse Events.

Cheryl A Allen1, Julius R Ivester2.   

Abstract

An old anesthetic agent, ketamine is finding new use in lower doses for analgesic purposes. There are concerns stemming from its potential side effects-specifically psychomimetic effects. These side effects are directly related to dose amount. The doses used for analgesic purposes are much lower than those used for anesthesia purposes. A literature review was performed to ascertain potential side effects and/or adverse events when using ketamine for analgesia purposes. The search included CINAHL, PubMed, and Ovid using the search terms "ketamine," "ketamine infusion," "pain," "adverse events," "practice guideline," and "randomized controlled trial." Searches were limited to full-text, peer-reviewed articles and systematic reviews. Initially 1,068 articles were retrieved. The search was then narrowed by using the Boolean connector AND with various search term combinations. After adjusting for duplication, article titles and abstracts were reviewed, leaving 25 articles for an in-depth analysis. Specific exclusion criteria were then applied. The literature supports the use of ketamine for analgesic purposes, and ketamine offers a nonopioid option for the management of some pain conditions. Because ketamine is still classified as an anesthetic agent, health care institutions should develop their own set of policies and protocols for the administration of ketamine. By using forethought and understanding of the properties of ketamine, appropriate care may be planned to mitigate potential side effects and adverse events so that patients are appropriately cared for and their pain effectively managed.
Copyright © 2017 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28743507     DOI: 10.1016/j.pmn.2017.05.006

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  5 in total

1.  Propofol-Ketamine vs. Propofol-Fentanyl Combinations in Patients Undergoing Closed Reduction: A Randomized, Double-blind, Clinical Trial.

Authors:  Mani Mofidi; Roghayeh Rouhi; Babak Mahshidfar; Saeed Abbasi; Peyman Hafezimoghadam; Mahdi Rezai; Davood Farsi
Journal:  Adv J Emerg Med       Date:  2018-09-04

2.  Low-dose intravenous ketamine versus intravenous ketorolac in pain control in patients with acute renal colic in an emergency setting: a double-blind randomized clinical trial.

Authors:  Mehran Sotoodehnia; Mozhgan Farmahini-Farahani; Arash Safaie; Fatemeh Rasooli; Alireza Baratloo
Journal:  Korean J Pain       Date:  2019-04-01

3.  Comparison of the efficacy of intranasal ketamine versus intravenous ketorolac on acute non-traumatic headaches: a randomized double-blind clinical trial.

Authors:  Hooman Rafiei Sarvari; Hamidreza Baigrezaii; Mohammad Nazarianpirdosti; Amirhossein Meysami; Roya Safari-Faramani
Journal:  Head Face Med       Date:  2022-01-03       Impact factor: 2.151

Review 4.  Perioperative Low-Dose Ketamine for Postoperative Pain Management in Spine Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Lijin Zhou; Honghao Yang; Yong Hai; Yunzhong Cheng
Journal:  Pain Res Manag       Date:  2022-03-31       Impact factor: 3.037

5.  Restoration of Sarco/Endoplasmic Reticulum Ca2+-ATPase Activity Functions as a Pivotal Therapeutic Target of Anti-Glutamate-Induced Excitotoxicity to Attenuate Endoplasmic Reticulum Ca2+ Depletion.

Authors:  Wen Zhang; Fanghua Ye; Nan Pang; Miriam Kessi; Juan Xiong; Shimeng Chen; Jing Peng; Li Yang; Fei Yin
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.